SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-05-001386
Filing Date
2005-08-05
Accepted
2005-08-05 16:42:35
Documents
7
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 bp71623.htm 10-Q 275341
2 bp71623ex1013.htm EX-10.13 12800
3 GRAPHIC image001.gif GRAPHIC 2065
4 bp71623ex311.htm EX-31.1 13563
5 bp71623ex312.htm EX-31.2 13593
6 bp71623ex321.htm EX-32.1 2966
7 bp71623ex322.htm EX-32.2 2972
  Complete submission text file 0001206774-05-001386.txt   325633
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 051003229
SIC: 2836 Biological Products, (No Diagnostic Substances)